(Q34519089)

2 August 2017

title

Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension (English)

1 reference

2 August 2017

1 reference

Marshall AJ

1

1 reference

2 August 2017

Kettle MA

series ordinal

2

1 reference

2 August 2017

Barritt DW

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 September 1980

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

217-221

1 reference

Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Clinical evaluation of indoramin, a new antihypertensive agent

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

The alpha-adrenoceptor blocking effect of indoramin on human isolated smooth muscle.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Beta blockade in essential hypertension: an analysis of response to oxprenolol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Pharmacokinetics of indoramin in man

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Pre- and postsynaptic α-adrenoceptor antagonism by indoramin in isolated tissues of the rat

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430069

Pharmacologic studies of indoramin in man

28 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7437237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Atenolol and bendrofluazide in hypertension

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7437237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1980.TB01747.X

1 reference

2 August 2017

1 reference

2 August 2017

1 reference